Sign In
Buy AQST
$4.03
+0.100 (+2.54%)
At Close: Jun 03, 2026
Aquestive Therapeutics (AQST) Receives a Buy from Wedbush - Markets
12:16pm, Sunday, 14'th Jun 2020
In a report issued on June 12, Liana Moussatos from Wedbush maintained a Buy rating on Aquestive Therapeutics (AQST –
Aquestive Therapeutics to Hold Virtual-Only Annual Meeting of Stockholders
09:05pm, Thursday, 04'th Jun 2020
Aquestive Therapeutics, Inc. (AQST), a pharmaceutical company focused on developing and commercializing differentiated products that address patients’ unmet needs and solve therapeutic problems, tod
Implied Volatility Surging for Aquestive Therapeutics (AQST) Stock Options
01:42pm, Thursday, 28'th May 2020
Investors need to pay close attention to Aquestive Therapeutics (AQST) stock based on the movements in the options market lately.
Why Aquestive Therapeutics (AQST) Stock Might be a Great Pick
01:22pm, Wednesday, 27'th May 2020
Aquestive Therapeutics (AQST) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
The Daily Biotech Pulse: FDA Nod For Aquestive, Tetraphase M&A Plot Thickens, Amarin's Vascepa In COVID Fray
11:10am, Friday, 22'nd May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 21) * ADC Therapeutics SA (NYSE: ADCT) (IPOed May 15) * A
Aquestive Therapeutics, Inc. (AQST), a pharmaceutical company focused on developing and commercializing differentiated products that address patients’ unmet needs and solve therapeutic problems, tod
The Daily Biotech Pulse: Mixed Filgotinib Readout For Gilead-Galapagos, Akorn To File For Chapter 11, D-Day For Aquestive
12:00am, Thursday, 21'st May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs on May 20.)
ADC Therapeutics SA (...
Is Aquestive Therapeutics (AQST) Outperforming Other Medical Stocks This Year?
03:30pm, Wednesday, 20'th May 2020
Is (AQST) Outperforming Other Medical Stocks This Year?
The Week Ahead In Biotech: Aquestive Awaits FDA Decision, Earnings Flow Slows
12:00am, Sunday, 17'th May 2020
Biotech stocks had another up week, with the American Society of Gene & Stem Cell Therapy virtual conference presentations and the ASCO abstracts made available online ...
Aquestive Therapeutics' Shares March Higher, Can It Continue?
12:25pm, Thursday, 14'th May 2020
As of late, it has definitely been a great time to be an investor in Aquestive Therapeutics.
All You Need to Know About Aquestive Therapeutics (AQST) Rating Upgrade to Buy
04:00pm, Tuesday, 12'th May 2020
Aquestive Therapeutics (AQST) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Publicly-traded companies blasted for taking small business loans. Those from N.J. got $32M.
12:30pm, Sunday, 10'th May 2020
The companies, however, returned 2/3 of the loans they received under the paycheck protection program.
Aquestive Therapeutics, Inc. (AQST) CEO Keith Kendall on Q1 2020 Results - Earnings Call Transcript
10:13am, Sunday, 10'th May 2020
Aquestive Therapeutics, Inc. (NYSE:HEI) Q1 2020 Earnings Conference Call May 07, 2020, 08:00 AM ET Company Participants Stephanie Carrington - Westwicke, IR Kei
Benzinga Pro's Top 5 Stocks To Watch For Fri., May 8, 2020: KC, IDXX, LAZY, AQST, AN
12:15pm, Friday, 08'th May 2020
Today's 5 Stock Ideas: * Kingsoft Cloud (KC) \- A new issue expected to open Friday morning. The company is one of China's top cloud service providers. Shares were expected in the $16-$18/share rang
Aquestive Therapeutics to Present at 2020 RBC Capital Markets Global Healthcare Conference
06:00pm, Thursday, 07'th May 2020
Aquestive Therapeutics, Inc. (AQST), a pharmaceutical company focused on developing and commercializing differentiated products that address patients’ unmet needs and solve therapeutic problems, tod
